Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 620

1.

High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia.

Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I.

Am J Med. 1998 Jun;104(6):517-25.

PMID:
9674713
[PubMed - indexed for MEDLINE]
2.

The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.

Antunes AA, Srougi M, Dall'oglio MF, Vicentini F, Paranhos M, Freire GC.

J Sex Med. 2008 Jul;5(7):1702-7. doi: 10.1111/j.1743-6109.2007.00713.x.

PMID:
18194186
[PubMed - indexed for MEDLINE]
3.

Interpreting results of prostate-specific antigen testing for early detection of prostate cancer.

Meigs JB, Barry MJ, Oesterling JE, Jacobsen SJ.

J Gen Intern Med. 1996 Sep;11(9):505-12.

PMID:
8905498
[PubMed - indexed for MEDLINE]
4.

Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level.

Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM.

Cancer. 2006 Apr 1;106(7):1507-13.

PMID:
16518812
[PubMed - indexed for MEDLINE]
Free Article
5.

Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians.

Coley CM, Barry MJ, Fleming C, Mulley AG.

Ann Intern Med. 1997 Mar 1;126(5):394-406. Review.

PMID:
9054286
[PubMed - indexed for MEDLINE]
6.

Behavioral associations between prostate and colon cancer screening.

Carlos RC, Underwood W 3rd, Fendrick AM, Bernstein SJ.

J Am Coll Surg. 2005 Feb;200(2):216-23.

PMID:
15664097
[PubMed - indexed for MEDLINE]
8.

Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.

Hammarsten J, Högstedt B.

Scand J Urol Nephrol. 2002;36(5):330-8.

PMID:
12487736
[PubMed - indexed for MEDLINE]
9.

Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.

Smith DS, Carvalhal GF, Mager DE, Bullock AD, Catalona WJ.

J Urol. 1998 Nov;160(5):1734-8.

PMID:
9783942
[PubMed - indexed for MEDLINE]
10.

A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma.

Spencer BA, Babey SH, Etzioni DA, Ponce NA, Brown ER, Yu H, Chawla N, Litwin MS.

Cancer. 2006 Feb 15;106(4):765-74.

PMID:
16419068
[PubMed - indexed for MEDLINE]
Free Article
11.

Prevalence of prostate specific antigen testing for prostate cancer in elderly men.

Dyche DJ, Ness J, West M, Allareddy V, Konety BR.

J Urol. 2006 Jun;175(6):2078-82.

PMID:
16697807
[PubMed - indexed for MEDLINE]
12.

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

Sirovich BE, Schwartz LM, Woloshin S.

JAMA. 2003 Mar 19;289(11):1414-20.

PMID:
12636464
[PubMed - indexed for MEDLINE]
13.

Obesity and prostate cancer screening among African-American and Caucasian men.

Fowke JH, Signorello LB, Underwood W 3rd, Ukoli FA, Blot WJ.

Prostate. 2006 Sep 15;66(13):1371-80.

PMID:
16752375
[PubMed - indexed for MEDLINE]
15.

Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy.

Scorilas A, Yu H, Soosaipillai AR, Gregorakis AK, Diamandis EP.

Clin Chim Acta. 2000 Feb 25;292(1-2):127-38.

PMID:
10686282
[PubMed - indexed for MEDLINE]
16.

Prostate cancer detection in candidates for open prostatectomy.

Fowler JE Jr, Bigler SA, Kolski JM.

J Urol. 1998 Dec;160(6 Pt 1):2107-10.

PMID:
9817333
[PubMed - indexed for MEDLINE]
17.

Prostate-specific antigen screening among young men in the United States.

Scales CD Jr, Antonelli J, Curtis LH, Schulman KA, Moul JW.

Cancer. 2008 Sep 15;113(6):1315-23. doi: 10.1002/cncr.23667.

PMID:
18696715
[PubMed - indexed for MEDLINE]
Free Article
18.

Prostate-specific antigen-enhanced testing and risk stratification for chemoprevention trials.

Moul JW.

Urology. 2001 Apr;57(4 Suppl 1):174-7.

PMID:
11295620
[PubMed - indexed for MEDLINE]
19.

Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.

Kok ET, Schouten BW, Bohnen AM, Groeneveld FP, Thomas S, Bosch JL.

J Urol. 2009 Feb;181(2):710-6. doi: 10.1016/j.juro.2008.10.025. Epub 2008 Dec 16.

PMID:
19091352
[PubMed - indexed for MEDLINE]
20.

Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System.

Li J, Zhao G, Pollack LA, Smith JL, Joseph DA.

Prev Chronic Dis. 2010 Jul;7(4):A84. Epub 2010 Jun 15.

PMID:
20550842
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk